PYXS financials
Pyxis Oncology (PYXS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- PYXS revenue was $13.86M in fiscal 2025, net income -$79.62M.
PYXS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $13.86M | $11.47M | -$84.42M | -$79.62M | -1.28 |
| 2024 | $16.15M | $15.67M | -$89.46M | -$77.33M | -1.32 |
| 2023 | – | – | -$82.20M | -$73.79M | -1.85 |
| 2022 | – | – | -$123.48M | -$120.72M | -3.65 |
| 2021 | – | – | -$69.72M | -$75.97M | -8.95 |
| 2020 | – | – | -$12.89M | -$12.83M | -12.45 |